Search
For oxygen-deprived newborns, rewarming after cooling therapy can trigger seizures: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/oxygen-deprived-newborns.html
Oxygen-deprived newborns who undergo cooling therapy to protect their brains are at an elevated risk of seizures and brain damage during the rewarming period, which could be a precursor of disability or death
UTSW study finds Hispanic people receive lower-quality thrombectomies than white people: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/lower-quality-thrombectomies.html
A study by UT Southwestern neurology researchers found that Hispanic people have lower-quality outcomes than white people among ischemic stroke patients who receive endovascular thrombectomies. Racial disparities were not found between Black and white patients.
UTSW working to reprogram cells to strengthen immunity in geriatric patients: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/reprogramming-cells.html
What if the key to aging well lies in reprogramming immune system cells to strengthen them against infections and cancer? Researchers at UT Southwestern are working to find out.
UT Southwestern mourns loss of W.A. “Tex” Moncrief Jr., whose generosity extended academic medical care and research through generations: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/moncrief-jr-obit.html
W.A. “Tex” Moncrief Jr., whose extraordinary generosity has and will benefit many generations of Texans by expanding UT Southwestern Medical Center programs in Dallas and especially Fort Worth, as well as surrounding communities, died Dec. 28 at age 101.
UTSW physician named 2022 National Academy of Medicine Scholar in Diagnostic Excellence: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-nam-scholar.html
Reuben Arasaratnam, M.D., M.P.H., Assistant Professor of Internal Medicine at UT Southwestern, has been named one of 11 2022 Scholars in Diagnostic Excellence by the National Academy of Medicine (NAM).
UTSW study finds it safe to give clot-busting drug to stroke patients who took blood thinners: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/clot-busting-drug.html
Stroke patients on long-term blood thinners who were given the clot-busting drug alteplase enjoyed better recoveries than those who did not receive the drug and had no increased risk of bleeding, a new study led by UTSW researchers shows.
Researchers find immune component to rare neurodegenerative disease : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/neurodegenerative-disease.html
UT Southwestern researchers have identified an immune protein tied to the rare neurodegenerative condition known as Niemann-Pick disease type C.
UT Southwestern scientists closing in on map of the mammalian immune system: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/mammalian-immune-system.html
Using artificial intelligence, UT Southwestern scientists have identified thousands of genetic mutations likely to affect the immune system in mice. The work is part of one Nobel laureate’s quest to find virtually all such variations in mammals.
Study finds no danger of second COVID shot in those with allergic reactions to first dose: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/second-covid-shot.html
People who had a potentially allergic reaction to their first messenger RNA COVID-19 vaccination can safely receive their second shot, according to a study of patients conducted at several medical centers, including UT Southwestern.
National Cancer Institute renews Simmons Cancer Center’s prestigious comprehensive designation: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/nci-renews-scc.html
The National Cancer Institute has renewed the Harold C. Simmons Comprehensive Cancer Center’s comprehensive designation, reaffirming its place among the country’s elite cancer institutes.